---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-001231"
form_type: "8-K"
ticker: "BCRX"
cik: "0000882796"
company_name: "BIOCRYST PHARMACEUTICALS INC"
filed_at: "2025-03-04T23:59:59+00:00"
generated_at: "2026-05-25T16:33:25.923571+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BioCryst CFO Anthony Doyle to resign effective April 9, 2025; search underway

## Summary
- Anthony Doyle notified resignation as CFO effective April 9, 2025.
- Resignation is not due to any disagreement with the company.
- Company has initiated a search for a new CFO; Doyle will remain to assist transition.
- Doyle joined in April 2020, helped launch ORLADEYO and strengthen financial position.

## SEC filing metadata
- accession: 0001171843-25-001231
- form_type: 8-K
- ticker: BCRX
- cik: 0000882796
- company_name: BIOCRYST PHARMACEUTICALS INC
- filed_at: 2025-03-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882796/000117184325001231/0001171843-25-001231-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882796/000117184325001231/f8k_030425.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-001231
- JSON: https://secwatch.observer/filing/0001171843-25-001231.json
- Plain text: https://secwatch.observer/filing/0001171843-25-001231.txt

## Key facts
- Executive change
  Anthony Doyle resigned as Chief Financial Officer at BIOCRYST PHARMACEUTICALS INC.
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On February 28, 2025, Anthony Doyle, the Chief Financial Officer of BioCryst Pharmaceuticals, Inc. (the “Company”) notified the Company of his intention to resign from his employment with the Company, effective April 9, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/882796/000117184325001231/0001171843-25-001231-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.